论文部分内容阅读
当前,一些不法药贩,趁医药市场开放搞活之机,制造贩卖假劣药品,近几个月来,外地来我市贩卖假药的重大案例连续发生两起,价值38,560元.还有的药贩,贩卖假药后即逃跑,给查处造成很大困难.为深入贯彻《药品管理法》加强医药市场的管理,在不影响医药市场开放搞活的前题下,试提出如下整顿建议.一、凡推销药品者,必须持有关证件,到当地卫生局药政科办理登记手续,经审批发证后,方可在当地销售药品,并取样品备案.二、各药品经营使用单位一律不准收购没有办理登记签证手续的单位和个人推销的药品.对购进没有经过签证的药品的单位和个人,
At present, some unscrupulous drug dealers have taken the opportunity to open up and revitalize the pharmaceutical market to manufacture counterfeit drugs for sale. In recent months, there have been two consecutive major cases involving the sale of counterfeit drugs from other places in the city to China with a value of 38,560 yuan. Fled after trafficking, selling counterfeit drugs, causing great difficulties in the investigation and handling.To implement the “Drug Administration Law” to strengthen the management of the pharmaceutical market, without affecting the pharmaceutical market open and invigorated the premise, try to put forward the rectification recommendations as follows: First, Those who sell drugs, must hold the relevant documents, go to the local Health Bureau Pharmaceutical Branch registration procedures, after the examination and approval, before the local sales of drugs, and take samples for the record. 二, the use of pharmaceutical companies are not allowed to purchase units There is no handling of the registration procedures for the sale of drugs and individuals units on the purchase of goods without a visa of the units and individuals,